HS
EPIX

HighVista Strategies’s ESSA Pharma EPIX Stock Holding History

HighVista Strategies’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-143,566
Closed -$1.15M – 82
2021
Q3 		$1.15M Buy
143,566
+119,540
+498% +$1.9M 0.76% 43
2021
Q2 		$686K Buy
+24,026
New +$698K 0.49% 64

Other funds holding EPIX

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

HighVista Strategies's EPIX Position: Q4 2021 in Review

HighVista Strategies sold out of ESSA Pharma (EPIX) in Q4 2021, closing a stake of 143,566 shares — an estimated $1.15M sold.

HighVista Strategies first reported a position in EPIX in Q2 2021 and held it in 2 quarters. The position peaked at $1.15M in Q3 2021. 60 funds tracked by Wall St. Rank hold EPIX as of Q4 2021.

  • HighVista Strategies reported no remaining ESSA Pharma position as of Q4 2021 after selling out during the quarter.
  • HighVista Strategies sold 143,566 ESSA Pharma shares in Q4 2021, an estimated $1.15M.
  • HighVista Strategies first reported a position in ESSA Pharma in Q2 2021 and held it in 2 quarters.
  • HighVista Strategies's ESSA Pharma position peaked at $1.15M in Q3 2021.
  • 60 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2021.

Based on HighVista Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.